Evidence map›Paper›PMID 42936420›Full record

ReviewFrontiers in medicine2026

Artificial intelligence for full-cycle clinical management in orthokeratology: a comprehensive review.

Xiaotong Wang, Haojiang Yang

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaotong WangSchool of Medicine, Shenzhen University, Shenzhen, China.
Haojiang YangDepartment of Ophthalmology, Shenzhen Second People's Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global myopia epidemic, especially among children, poses a major public health burden. Orthokeratology (OK) is an established intervention for slowing myopia progression, yet its conventional practice is constrained by variable treatment responses, an experience-dependent fitting process, and the need for vigilant long-term safety monitoring. Artificial intelligence (AI) offers an approach to enhance precision, efficiency, and accessibility across the entire OK care cycle. This review assesses AI applications in OK, encompassing pre-treatment efficacy prediction, AI-assisted lens fitting and automated fit assessment during treatment, and post-treatment safety monitoring with complication risk alert. Evidence indicates that AI models perform comparably to, and in some tasks surpass, human experts in predicting outcomes and determining optimal lens parameters. However, translation from research to routine practice is hindered by limited data quality and diversity, the opacity of complex algorithms, insufficient external validation, and unresolved ethical concerns. Progress depends on building large-scale, diverse datasets, developing interpretable and robust models, and fostering effective human-AI collaboration.

Indexed as

artificial intelligencedeep learningmyopia controlorthokeratologyprecision medicine

Identifiers

PMID42936420
PMCPMC13697254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.